ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

Women’s Health Initiative: Cutting Fat Has Small Effect On Breast Cancer Risk

February 24, 2006

Kimes, Lenfant, To Retire

July 11, 2003

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002

DRCCA Board, Subcommittee Approve Reorganization Of Education Program

February 5, 1982

NCI Health Disparities Center Will Attempt To Influence Policy, Harold Freeman Says.

November 3, 2000

NCI Considering Master Agreements For Cancer Centers

August 2, 1991